Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial

Mansoor Raza Mirza, Benedict B. Benigno, Anne Dørum, Sven Mahner, Paul Bessette, Isabel Bover Barceló, Dominique Berton-Rigaud, Jonathan A. Ledermann, B.J. Rimel, Jørn Herrstedt, Susie Lau, Andreas du Bois, A. Casado Herráez, Elsa Kalbacher, Joseph Buscema, Domenica Lorusso, Ignace Vergote, Tally Levy, P. Wang, Floris A. de Jong, Dhiraj Gupta, Ursula A. Matulonis